Cordone Susanna, Scarpelli Serena, Alfonsi Valentina, De Gennaro Luigi, Gorgoni Maurizio
UniCamillus, Saint Camillus International University of Health Sciences, 00131 Rome, Italy.
Department of Psychology, University of Rome "Sapienza", 00185 Rome, Italy.
Pharmaceuticals (Basel). 2021 Apr 19;14(4):383. doi: 10.3390/ph14040383.
The multifactorial nature of Alzheimer's disease (AD) has led scientific researchers to focus on the modifiable and treatable risk factors of AD. Sleep fits into this context, given the bidirectional relationship with AD confirmed by several studies over the last years. Sleep disorders appear at an early stage of AD and continue throughout the entire course of the pathology. Specifically, sleep abnormalities, such as more fragmented sleep, increase in time of awakenings, worsening of sleep quality and primary sleep disorders raise with the severity and progression of AD. Intervening on sleep, therefore, means acting both with prevention strategies in the pre-clinical phase and with treatments during the course of the disease. This review explores sleep disturbances in the different stages of AD, starting from the pre-clinical stage. Particular attention is given to the empirical evidence investigating obstructive sleep apnea (OSA) disorder and the mechanisms overlapping and sharing with AD. Next, we discuss sleep-based intervention strategies in the healthy elderly population, mild cognitive impairment (MCI) and AD patients. We mention interventions related to behavioral strategies, combination therapies, and bright light therapy, leaving extensive space for new and raising evidence on continuous positive air pressure (CPAP) treatment effectiveness. Finally, we clarify the role of NREM sleep across the AD trajectory and consider the most recent studies based on the promising results of NREM sleep enhancement, which use innovative experimental designs and techniques.
阿尔茨海默病(AD)的多因素性质促使科研人员关注AD的可改变和可治疗的风险因素。鉴于过去几年多项研究证实睡眠与AD之间存在双向关系,睡眠也符合这一范畴。睡眠障碍出现在AD的早期阶段,并在整个病理过程中持续存在。具体而言,睡眠异常,如睡眠更加碎片化、觉醒时间增加、睡眠质量恶化以及原发性睡眠障碍会随着AD的严重程度和进展而加剧。因此,干预睡眠意味着在临床前期采取预防策略,并在疾病过程中进行治疗。本综述从临床前期开始,探讨AD不同阶段的睡眠障碍。特别关注调查阻塞性睡眠呼吸暂停(OSA)障碍以及与AD重叠和共享的机制的实证证据。接下来,我们讨论健康老年人、轻度认知障碍(MCI)和AD患者基于睡眠的干预策略。我们提及与行为策略、联合疗法和强光疗法相关的干预措施,为持续气道正压通气(CPAP)治疗效果的新证据和不断增加的证据留出大量空间。最后,我们阐明非快速眼动睡眠在AD病程中的作用,并基于非快速眼动睡眠增强的有前景结果考虑最新研究,这些研究采用了创新的实验设计和技术。